Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Salk scientists discover protein that 'turns off' uncontrolled liver cancer growth

Salk scientists discover protein that 'turns off' uncontrolled liver cancer growth

FDA-approved inhibitors could be repurposed to target ARID1A-mutant ovarian cancers

FDA-approved inhibitors could be repurposed to target ARID1A-mutant ovarian cancers

MSU scientists test promising drug to prevent cancer in high-risk patients

MSU scientists test promising drug to prevent cancer in high-risk patients

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Researchers probe RNA epigenetics and chromatin structures to predict drug resistance in leukemia

Researchers find investigational compound to treat triple negative breast cancer after brain metastasis

Researchers find investigational compound to treat triple negative breast cancer after brain metastasis

Researchers prove link between common childhood cancer and inflammation

Researchers prove link between common childhood cancer and inflammation

Researchers show how two cancer genes work together to trigger leukemia

Researchers show how two cancer genes work together to trigger leukemia

IBN’s green tea-based drug nanocarriers show superior tumor-killing performance

IBN’s green tea-based drug nanocarriers show superior tumor-killing performance

NIH-funded researchers use CRISPR to rapidly find new genetic suspects behind ALS, FTD

NIH-funded researchers use CRISPR to rapidly find new genetic suspects behind ALS, FTD

Adolescent, young adult cancer survivors have stronger social networks than non-cancer peers

Adolescent, young adult cancer survivors have stronger social networks than non-cancer peers

Study finds prevalence of cognitive decline among elderly patients with blood-related cancers

Study finds prevalence of cognitive decline among elderly patients with blood-related cancers

Gene-editing technology enhances T cell immunotherapies for treating cancer

Gene-editing technology enhances T cell immunotherapies for treating cancer

Telomere length testing can alter treatment decisions for certain diseases

Telomere length testing can alter treatment decisions for certain diseases

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Researchers discover key inner control mechanism of cell's 'smart glue'

Researchers discover key inner control mechanism of cell's 'smart glue'

Research opens up new avenue to minimize risks of transplants

Research opens up new avenue to minimize risks of transplants

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

Blood or marrow transplantation survivors have higher risk of cognitive impairment

Blood or marrow transplantation survivors have higher risk of cognitive impairment

New NK cell-based immunotherapy effective against several types of leukemia

New NK cell-based immunotherapy effective against several types of leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.